KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Asset Writedowns and Impairment (2017 - 2026)

Johnson & Johnson's Asset Writedowns and Impairment history spans 18 years, with the latest figure at -$8.0 million for Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment fell 100.0% to -$8.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $200.0 million, a 50.12% decrease, with the full-year FY2025 number at $204.0 million, down 49.63% from a year prior.
  • Asset Writedowns and Impairment hit -$8.0 million in Q1 2026 for Johnson & Johnson, down from $81.0 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for JNJ hit a ceiling of $820.0 million in Q4 2023 and a floor of -$981.0 million in Q1 2023.
  • Historically, Asset Writedowns and Impairment has averaged $117.3 million across 5 years, with a median of $81.0 million in 2025.
  • Biggest five-year swings in Asset Writedowns and Impairment: skyrocketed 4792.31% in 2022 and later plummeted 100.0% in 2026.
  • Tracing JNJ's Asset Writedowns and Impairment over 5 years: stood at $610.0 million in 2022, then dropped by 22.13% to $475.0 million in 2023, then crashed by 94.53% to $26.0 million in 2024, then surged by 211.54% to $81.0 million in 2025, then tumbled by 109.88% to -$8.0 million in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for JNJ at -$8.0 million in Q1 2026, $81.0 million in Q4 2025, and $93.0 million in Q3 2025.